MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
*Funding: Surgery_Surgical Technology, Minimally Invasive & Operating Room of the Future (ORF)
*Venture Capital Companies: Life Science, Health IT & Healthcare Investors
Three Arch Partners-CCF
*Portfolio Companies: Three Arch
Talphera, Inc. (NASDAQ: TLPH<, formerly, AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)
Organization & Developments: AcelRx
Parents
Talphera, Inc. (NASDAQ: TLPH<, formerly, AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX)
Children
2015: AcelRx Pharmaceuticals: What Went Wrong and What's on the Horizon for the Struggling Biotech?
2017: AcelRx Pharmaceuticals: Blockbuster Potential Makes This $2 Stock A Strong Buy For 2017 - AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)
2017: AcelRx: Replacing Morphine With Department Of Defense Funding
2017: AcelRx: Undervalued Heading Into A Phase 3 Catalyst - AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)
2017: After Disappointing CRL For Dsuvia, What's Next For AcelRx? - AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)
2017: Jefferies likes AcelRx Pharma, sees more than a three-bagger; shares up 7% premarket - AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)
2018: AcelRX - The Military Angle That Could Boost Its Prospects_seekingalpha.com
2018: AcelRx refiles U.S. marketing application for Dsuvia, action date Q4; shares up 10% premarket_seekingalpha.com
2018: AcelRx_FDA approves powerful opioid despite fears of more overdose deaths
2018: AcelRx: A Valuation_seekingalpha.com
2018: Reversal of fortune for AcelRx Pharma, shares up 26% on potential Ad Com thumbs up for Dsuvia_seekingalpha.com
2019: AcelRx Has A Lot Of Obstacles, But There Could Be A Pot Of Gold At The End_seekingalpha.com
2020: AcelRx: Clever Solution To Painful Problem
2021: AcelRx Pharmaceuticals: Moving Closer To An Attractive Risk-Reward
2021: AcelRx Pharmaceuticals: Waiting For The Numbers To Close The Gap
2023: AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of pain and other conditions.
It offers NanoTab, a tablet for oral transmucosal administration.
Novel drug delivery platform technology
Specialty Pharmaceutical Company Focused on the Development and Commercialization of Innovative Therapies for the Treatment of Acute and Breakthrough Pain
The company also provides Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system with a drug/device combination.
Jumps
*Key People: AcelRx
Finance & Acquisitions: AcelRx